At the end of the period January-may 2020, Russia imported finished drugs in the amount 168,6 billion, according to the RNC Pharma. Ruble dynamics to the similar period in 2019 is still negative (-27%), but may was the first month of the current year in which the supply of ready-made medicines showed an increase: in may 2020, the volume of import by may 2019 was 16% greater when calculated in rubles. The natural volume of import of ready-made forms in may also increased markedly, it has been mentioned here +19% (in the calculation of packages).
Supply of bulk drugs to Russia in January-may 2020, on the contrary, increased. There are analysts pointed +12% in RUB total for the year, Russia imported bulk products in the amount of RUB 52.5 billion
General natural dynamics for the period from the beginning of the year, retains a negative value, so the supply of finished drugs for the year declined by 38% as measured in packs, only for the first 5 months of the current year Russia imported 0,43 billion packages.
In the top-20 corporations manufacturers of finished medicines on cash shipments in the January-may 2020 maximum dynamics in the ruble showed the company “Shaer pharmaceutical” (imports grew 3.9 times) and “BioMarin pharmaceutical” (2.4 times).